Literature DB >> 10868470

Service use and costs of people with dual diagnosis in South London.

P McCrone1, P R Menezes, S Johnson, H Scott, G Thornicroft, J Marshall, P Bebbington, E Kuipers.   

Abstract

OBJECTIVE: To compare the service use and costs of individuals who have a dual diagnosis of psychosis and substance abuse with those who have a diagnosis of psychosis but no substance abuse.
METHOD: Patients with psychosis were identified and a representative sample were interviewed. Six-month service use was measured and costs calculated. Regression models were developed to predict costs from background characteristics and dual diagnosis status.
RESULTS: A greater proportion of the patients with dual diagnosis used community psychiatric nurses, in-patient care and the emergency clinic. The regression analysis revealed that dual diagnosis patients had significantly higher 'core' psychiatric service costs (a difference of pound sterling 1362) and non-accommodation service costs (pound sterling 1360) than non-dual-diagnosis patients. The difference when all services were analysed was pound sterling 1046, but this was not statistically significant.
CONCLUSION: Specific interventions for dual diagnosis patients should be introduced and assessed in terms of individual outcomes, service use and costs.

Entities:  

Mesh:

Year:  2000        PMID: 10868470     DOI: 10.1034/j.1600-0447.2000.101006464.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  7 in total

1.  Ethnic differences in mental health service use among patients with psychotic disorders.

Authors:  Rajesh Mohan; Paul McCrone; George Szmukler; Nadia Micali; Sarah Afuwape; Graham Thornicroft
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-07-17       Impact factor: 4.328

Review 2.  Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review.

Authors:  Giuseppe Carrà; Sonia Johnson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-13       Impact factor: 4.328

3.  The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC).

Authors:  Giuseppe Carrà; Sonia Johnson; Paul Bebbington; Matthias C Angermeyer; Dirk Heider; Traolach Brugha; Jean-Michel Azorin; Mondher Toumi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-17       Impact factor: 5.270

4.  Use of health care services by patients with co-occurring severe mental illness and substance use disorders.

Authors:  Marius N Kêdoté; Astrid Brousselle; François Champagne
Journal:  Ment Health Subst Use       Date:  2008-09-19

5.  Examining factorial structure and measurement invariance of the Brief Symptom Inventory (BSI)-18 among drug users.

Authors:  Jichuan Wang; Brian C Kelly; Brenda M Booth; Russel S Falck; Carl Leukefeld; Robert G Carlson
Journal:  Addict Behav       Date:  2009-08-14       Impact factor: 3.913

6.  The association between continuity of care and readmission to hospital in patients with severe psychosis.

Authors:  Stephen Robert Puntis; Jorun Rugkåsa; Tom Burns
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-10-25       Impact factor: 4.328

7.  The Burnaby treatment center for mental health and addiction, a novel integrated treatment program for patients with addiction and concurrent disorders: results from a program evaluation.

Authors:  Christian Schütz; Isabelle Aubé Linden; Iris Torchalla; Kathy Li; Majid Al-Desouki; Michael Krausz
Journal:  BMC Health Serv Res       Date:  2013-07-30       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.